Results 171 to 180 of about 1,191,327 (361)

Gene therapy for ocular hypertension using hfCas13d-mediated mRNA targeting. [PDF]

PNAS Nexus
Chen S, Liu Z, Lo CH, Wang Q, Ning K, Zhang Q, Zhao J, Shen Y, Sun Y.   +8 more
europepmc   +1 more source

Comparison of Procedural and Clinical Outcomes of Angiography‐ Versus Imaging‐Guided Percutaneous Coronary Intervention With Intravascular Lithotripsy

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) is an innovative treatment for coronary artery calcification (CAC). Aims This study aimed to compare procedural and clinical outcomes of intracoronary imaging (ICI)‐guided percutaneous coronary intervention (PCI) versus angiography‐guided PCI with IVL in patients with CAC.
Akshay A. S. Phagu, Martijn J. H. van Oort, Federico Oliveri, Brian O. Bingen, Gianluca Mincione, Valeria Paradies, Bimmer E. P. M. Claessen, Aukelien C. Dimitriu‐Leen, Tessel N. Vossenberg, Joelle Kefer, Hany Girgis, Frank van der Kley, J. Wouter Jukema, Ibtihal Al Amri, Jose M. Montero‐Cabezas   +14 more
wiley   +1 more source

TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension. [PDF]

Elife
Rudzitis CN, Lakk M, Singh A, Redmon SN, Kirdajová D, Tseng YT, De Ieso ML, Stamer WD, Herberg S, Krizaj D.   +9 more
europepmc   +1 more source

Comparison of ambulatory blood pressure values in patients with glaucoma and ocular hypertension [PDF]

, 2003
Bülent Yazıcı, Emrah Usta, Halûk Ertürk, Kamıl Dilek   +3 more
openalex   +1 more source

Intravascular Lithotripsy for Calcific Coronary Bifurcations: Procedural Success and 1‐Year Clinical Outcomes

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) has emerged as a promising treatment for heavily calcified coronary lesions. However, evidence regarding its effectiveness in calcific bifurcation lesions remains limited. Objective We aimed to evaluate the technical success and 1‐year clinical outcomes of IVL in calcified coronary bifurcation lesions.
Federico Oliveri, Giulia D'Acunto, Martijn. J.H. van Oort, Akshay Phagu, Ibtihal Al Amri, Brian O. Bingen, Valeria Paradies, Gianluca Mincione, Bimmer E. Claessen, Aukelien C. Dimitriu‐Leen, Joelle Kefer, Hany Girgis, Tessel Vossenberg, Frank Van der Kley, J. Wouter Jukema, Josè M. Montero‐Cabezas   +15 more
wiley   +1 more source

Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension. [PDF]

Pharmaceuticals (Basel)
Matamoros JA, Rubio-Casado S, Fernández-Albarral JA, Martínez-López MA, Ramírez AI, Salobrar-García E, Marco EM, Paleo-García V, de Hoz R, López-Cuenca I, Elvira-Hurtado L, Sánchez-Puebla L, Ramírez JM, López-Gallardo M, Salazar JJ.   +14 more
europepmc   +1 more source

Frequency doubling technology and high‐pass resolution perimetry in glaucoma and ocular hypertension [PDF]

, 2003
Lada Kalaboukhova, Bertil Lindblom
openalex   +1 more source

Management of Lost Atherectomy Devices in the Coronary Arteries

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Rotational and orbital atherectomy are important tools to treat calcific coronary disease. Entrapment of an atherectomy device, that is, rotational atherectomy burr or orbital atherectomy crown, is a serious complication during atherectomy. Loss of an atherectomy device is a more challenging complication that usually follows device entrapment.
Gregor Leibundgut, Alexandru Achim, Daniel Weilenmann, Johannes Rigger, Fabian Gocht, Mohaned Egred, Bilal Murad, William Lombardi, M. Bilal Iqbal   +8 more
wiley   +1 more source

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT™) versus latanoprost 0.005% (XALATAN™) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials [PDF]

, 2003
Robert D. Fechtner, P. Juhani Airaksinen, Albert J. Getson, Christopher R. Lines, Ingrid Adamsons   +4 more
openalex   +1 more source

Perventricular Device Closure of Native Congenital Muscular Ventricular Septal Defects in Small Infants   $\hspace{0.17em}$ ≤ 5 kg: Single‐Center Study of the Risk Factors for Failure of the Intervention and Non‐Optimal Outcome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aims Perventricular device closure of muscular VSD in small infants is a less invasive option than surgical closure under cardiopulmonary bypass and offers better outcomes than palliative pulmonary artery banding. However, the specific risk factors that could affect procedural success and optimal outcomes have not been ...
Emine Hekim Yilmaz, Ilker Kemal Yucel, Murat Surucu, Huseyin Karadag, Ibrahim Halil Demir, Murat Cicek, Numan Ali Aydemir, Ahmet Celebi   +7 more
wiley   +1 more source